InflaRx N.V. (IFRX) Financials
IFRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 56.1 million | 13.8 million |
| Dec. 31, 2025 | 64.8 million | 16.0 million |
| Sept. 30, 2025 | 76.5 million | 23.2 million |
| June 30, 2025 | 86.6 million | 19.3 million |
IFRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -8.6 million | ? |
| Dec. 31, 2025 | -5.5 million | -4.2 million |
| Sept. 30, 2025 | -10.7 million | 699281 |
| June 30, 2025 | -8.9 million | 1.3 million |
IFRX Net Income
No data available :(
IFRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 45.7 million | - | 655870 |
| Dec. 31, 2025 | 54.5 million | - | 752157 |
| Sept. 30, 2025 | 52.4 million | - | 1.1 million |
| June 30, 2025 | 56.6 million | - | 706150 |
IFRX Shares Outstanding
IFRX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 11024 | 4.4 million | 3.5 million | - |
| Dec. 31, 2025 | 2405 | 5.0 million | 3.5 million | -1.9 million |
| Sept. 30, 2025 | 103237 | 7.3 million | 4.4 million | 1.4 million |
| June 30, 2025 | 17947 | 8.5 million | 5.0 million | 589330 |
IFRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 101549 |
| Dec. 31, 2025 | -41193 | 5.8 million |
| Sept. 30, 2025 | 27965 | 390 |
| June 30, 2025 | 46476 | 2.8 million |
IFRX
Price: $1.74
52 week price:
Earnings Per Share: -0.74 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 38219
Market Capitalization: 153.1 million